Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Kala Pharmaceuticals Inc

KALA
Current price
6.49 USD +0.3 USD (+4.85%)
Last closed 6.08 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 16 374 169 USD
Yield for 12 month +30.32 %
Week
Month
Year
KALA
21.11.2021 - 28.11.2021

KALA BIO, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of eye diseases. The company's product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development product, including KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts. Address: 1167 Massachusetts Avenue, Arlington, MA, United States, 02476

Analytics

WallStreet Target Price

19.67 USD

P/E ratio

Dividend Yield

Current Year

+3 892 000 USD

Last Year

+11 240 000 USD

Current Quarter

Last Quarter

Current Year

+1 332 000 USD

Last Year

+7 143 000 USD

Current Quarter

Last Quarter

Key Figures KALA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -38 653 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -33.18 %
PEG Ratio
Return On Equity TTM -905.22 %
Wall Street Target Price 19.67 USD
Revenue TTM
Book Value 4.17 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100 %
Dividend Yield
Gross Profit TTM 1 332 000 USD
Earnings Share -22.38 USD
Diluted Eps TTM -22.38 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics KALA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History KALA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:50
Payout Ratio
Last Split Date 21.10.2022
Dividend Date

Stock Valuation KALA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.0421
Price Sales TTM 1.157
Enterprise Value EBITDA 0.0857
Price Book MRQ 1.4734

Financials KALA

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators KALA

For 52 weeks

3.54 USD 56.72 USD
50 Day MA 7.3 USD
Shares Short Prior Month 63 306
200 Day MA 12.77 USD
Short Ratio 4.27
Shares Short 63 394
Short Percent 2.45 %